Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Metabolism

Temperature-Acclimated Brown Adipose Tissue Modulates Insulin Sensitivity in Humans

  1. Paul Lee1,
  2. Sheila Smith1,
  3. Joyce Linderman1,
  4. Amber B. Courville2,
  5. Robert J. Brychta1,
  6. William Dieckmann3,
  7. Charlotte D. Werner1,
  8. Kong Y. Chen1 and
  9. Francesco S. Celi1,4⇑
  1. 1Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
  2. 2Department of Nutrition, Clinical Center, National Institutes of Health, Bethesda, MD
  3. 3PET Department, Clinical Center, National Institutes of Health, Bethesda, MD
  4. 4Division of Endocrinology and Metabolism, Virginia Commonwealth University, Richmond, VA
  1. Corresponding author: Francesco S. Celi, fsceli{at}vcu.edu.
Diabetes 2014 Nov; 63(11): 3686-3698. https://doi.org/10.2337/db14-0513
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Temperature-dependent BAT acclimation. A–D: Representative PET/CT fused images of the cervical-supraclavicular region (left panels: coronal view; right panels: transverse view) of one subject during monthly temperature acclimation. BAT (HU: −300 to −10 and SUV ≥2) is shown in red. Baseline BAT volume and mean SUV and activity were 26 mL and 2.65 and 0.238 MBq, respectively (A). All BAT parameters increased after 1 month of mild cold acclimation (19°C) (B), decreased to nearly baseline level after the thermoneutral month (24°C) (C), and BAT was nearly completely muted at the end of the 1-month mild warm exposure in the final month (27°C) (D). Mean fold changes (N = 5) of BAT volume (E) and mean SUV (F) and BAT activity (G), relative to month 1 (24°C), were significant across 4-month acclimation. Whole fat activity, as defined by 18F-fluodeoxyglucose uptake within tissue of fat density (HU: −300 to −10), followed the same pattern (H) and interacted significantly with temperature acclimation. Room (I) and individual exposed temperatures (J), but not environmental seasonal fluctuations (I), tracked BAT and whole fat metabolic changes in the predicted temperature-dependent manner. Correlative analysis between BAT parameters and temperature exposure is shown in Supplementary Table 1. Individual PET/CT images and temperature profiles are shown in Supplementary Figs. 4–7. *P < 0.05 compared with month 1 (24°C); #P < 0.05 compared with month 2 (19°C).

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Metabolic consequences of BAT acclimation at 19°C. A and B: Comparison of postprandial glucose and insulin excursions after a mixed meal at 1300 h before and after cold acclimation, respectively, measured at 19°C. Glucose excursions were unchanged but insulin levels decreased, with a significant reduction in AUC, after mild cold acclimation (month 2). Accordingly, adipocyte insulin resistance (IR) was the lowest (C) and Matsuda index (an indicator of insulin sensitivity) was the highest (D) after cold acclimation (month 2). These changes in glucose metabolism were accompanied by an increase in circulating adiponectin (E) and a decrease in circulating leptin (F). Cold acclimation–induced changes (months 1 and 2) in circulating adiponectin (G) and leptin levels (H) correlated negatively with changes in BAT activity. Adiponectin and leptin mRNA displayed concordant changes in subcutaneous adipose tissue biopsies with circulating levels, and changes in GLUT4 tracked those of adiponectin (I). aP < 0.05 compared with month 1 (24°C), bP < 0.05 compared with month 2 (19°C), cP < 0.05 compared with month 3 (24°C), and dP < 0.05 compared with month 4 (27°C).

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Metabolic consequences of BAT acclimatization at 24°C. A and B: Comparison of postprandial glucose and insulin excursions after a mixed meal at 1300 h before and after cold acclimatization, respectively, measured at 24°C. Unlike measurements at 19°C (Fig. 2A and B), no significant changes were observed in glucose or insulin excursions. Accordingly, adipocyte insulin resistance (IR) (C) and Matsuda index (an indicator of insulin sensitivity) (D) were unchanged. Circulating adiponectin increased (E), while leptin decreased (F), identical to measurements observed at 19°C (Fig. 2E and F). Cold acclimatization–induced changes (months 1 and 2) in circulating adiponectin (G) and leptin levels (H) correlated negatively with changes in BAT activity. In contrast to that observed in adipose tissue (Fig. 2I), adiponectin and GLUT4 mRNA did not change significantly in muscle (I). cP < 0.05 compared with month 3 (24°C); dP < 0.05 compared with month 4 (27°C).

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    BAT and beige fat gene changes in adipose tissue biopsies across 4-month acclimatization. A: Changes in general BAT gene expression (general BAT genes are defined as genes ascribed to general BAT function and do not indicate their developmental origin). Expression of CIDEA, but not others, changed significantly (P = 0.04) during acclimatization across 4-month period. B: Changes in classic BAT gene expression. Classic BAT genes are defined as those expressed in interscapular BAT in animals or human infants (50). C: Changes in beige fat gene expression. Beige fat genes are defined as those expressed in inducible brown adipocytes, also known as brite or beige adipocytes, found within WAT depots. No significant changes were observed in classic BAT or beige fat genes across temperature acclimation.

Tables

  • Figures
  • Table 1

    PET/CT parameters across 4 months of acclimation

    Month 1: 24°CMonth 2: 19°CMonth 3: 24°CMonth 4: 27°CPtrend
    BAT volume (mL)55 ± 6178 ± 84a63 ± 8158 ± 810.036
    BAT mean SUV3.2 ± 0.83.8 ± 1.33.4 ± 1.03.4 ± 0.80.35
    BAT activity (MBq)0.65 ± 0.761.0 ± 1.3a0.8 ± 1.10.7 ± 1.00.038
    BAT radiodensity (HU)−58.8 ± 7.2−44.2 ± 6.8−55.4 ± 6.5−69.2 ± 6.8<0.01
    Whole fat mean SUV0.61 ± 0.130.68 ± 0.18a0.63 ± 0.170.59 ± 0.160.035
    Muscle mean SUV0.46 ± 0.080.41 ± 0.040.43 ± 0.050.48 ± 0.080.52
    Liver mean SUV1.68 ± 0.081.50 ± 0.141.61 ± 0.151.67 ± 0.160.15
    • Data are means ± SD. At the end of each testing month, subjects underwent acute thermometabolic evaluation at either 24°C or 19°C.

    • aP < 0.05 (month 1 vs. 2).

  • Table 2

    Physiologic parameters across 4 months of acclimation

    Month 1: 24°CMonth 2: 19°CMonth 3: 24°CMonth 4: 27°CPtrend
    24°C19°C24°C19°C24°C19°C24°C19°C24°C19°C
    Total EE (kcal)2,472 ± 1802,624 ± 198a2,366 ± 3582,543 ± 410a2,400 ± 2522,555 ± 346a2,341 ± 2552,505 ± 322a0.450.46
    Respiratory quotient0.84 ± 0.030.84 ± 0.010.84 ± 0.020.83 ± 0.020.85 ± 0.020.84 ± 0.020.84 ± 0.030.85 ± 0.020.720.47
    Total activity (units)8.4 ± 1.68.4 ± 2.87.6 ± 2.97.1 ± 2.46.8 ± 3.77.1 ± 4.17.9 ± 5.07.2 ± 4.70.540.38
    Surface electromyography (×10−6 RMS)2.8 ± 0.42.5 ± 1.32.7 ± 0.32.6 ± 0.22.8 ± 0.52.7 ± 0.22.8 ± 0.32.6 ± 0.40.980.83
    CIT (%)6.2 ± 4.17.4 ± 3.16.2 ± 3.96.8 ± 3.20.16
    DIT (%)10.3 ± 13.133.4 ± 18.219.0 ± 15.442.2 ± 17.4a,b19.1 ± 16.037.1 ± 19.6a22.5 ± 11.034.4 ± 19.2a0.300.36
    • Data are means ± SD. At the end of each testing month, subjects underwent acute thermometabolic evaluation at either 24°C or 19°C. RMS, root mean square.

    • aP < 0.05 compared with 24°C during acute thermometabolic evaluation each month;

    • bP < 0.05 (month 1 vs. 2) compared with matching measurement at same temperature performed at respective months as indicated.

  • Table 3

    Nutritional and body compositional parameters across 4 months of acclimation

    Month 1: 24°CMonth 2: 19°CMonth 3: 24°CMonth 4: 27°CPtrend
    Dietary intake
     Caloric (kcal/day)2,530 ± 3212,620 ± 4122,623 ± 3422,514 ± 3590.32
     Protein (g/day)126 ± 16131 ± 19131 ± 15127 ± 180.35
     Fat (g/day)88 ± 991 ± 1393 ± 1186 ± 100.16
     Carbohydrate (g/day)319 ± 42331 ± 51329 ± 44320 ± 480.44
    Appetite/hunger VAS
     Hunger AUC13.1 ± 6.320.7 ± 7.017.5 ± 6.115.5 ± 3.50.13
     Satiety AUC35.8 ± 4.625.7 ± 8.525.5 ± 5.427.9 ± 7.90.09
     Desire to eat AUC14.6 ± 4.320.1 ± 3.4a,b17.9 ± 4.216.5 ± 5.30.003
    Body composition
     Body weight (kg)74.4 ± 7.374.8 ± 7.574.9 ± 7.474.7 ± 7.70.72
     Lean mass (kg)55.8 ± 6.056.3 ± 6.156.6 ± 6.356.1 ± 6.40.56
     Fat mass (kg)14.6 ± 0.514.5 ± 0.814.6 ± 1.414.7 ± 1.70.95
     % body fat20.92 ± 2.0020.62 ± 1.6420.64 ± 2.2220.88 ± 2.510.99
    • Data are means ± SD. At the end of each testing month, subjects underwent acute thermometabolic evaluation at either 24°C or 19°C.

    • aP < 0.05 (month 1 vs. 2),

    • bP < 0.05 (months 2 vs. 4) compared with matching measurement at same temperature performed at respective months as indicated.

  • Table 4

    Hormonal and metabolic parameters across 4 months of acclimation

    Month 1: 24°CMonth 2: 19°CMonth 3: 24°CMonth 4: 27°CPtrend
    24°C19°C24°C19°C24°C19°C24°C19°C24°C19°C
    Sympathoadrenal
     Urinary epinephrine (μg/day)7.5 ± 5.08.0 ± 4.87.5 ± 3.98.3 ± 5.67.5 ± 4.47.7 ± 4.68.3 ± 6.17.7 ± 5.10.970.94
     Urinary norepinephrine (μg/day)46 ± 2953 ± 1456 ± 3064 ± 2035 ± 961 ± 18a37 ± 558 ± 240.420.56
    Glucocorticoid axis
     ACTH AUC (pg ⋅ min/mL)207 ± 61199 ± 73199 ± 51197 ± 65203 ± 74176 ± 61209 ± 71199 ± 830.200.40
     Cortisol AUC (μg ⋅ min/mL)0.96 ± 0.140.91 ± 0.130.87 ± 0.100.95 ± 0.120.81 ± 0.130.84 ± 0.170.90 ± 0.150.88 ± 0.220.140.39
     Urinary cortisol (μg/day)49 ± 936 ± 1349 ± 2739 ± 939 ± 1138 ± 1139 ± 2249 ± 210.420.25
    Thyroid axis
     TSH AUC (μIU ⋅ min/mL)7.8 ± 3.58.0 ± 2.87.5 ± 3.67.3 ± 2.18.6 ± 4.37.3 ± 2.28.8 ± 3.5c7.6 ± 1.90.380.39
     Free T4 AUC (pg ⋅ min/mL)95 ± 1395 ± 993 ± 1292 ± 1293 ± 993 ± 1190 ± 994 ± 90.390.54
     Free T3 AUC (pg ⋅ min/mL)26 ± 127 ± 129 ± 2b28 ± 128 ± 327 ± 226 ± 2d28 ± 20.160.59
     Free T3/free T4 AUC2,381 ± 4902,410 ± 3452,642 ± 574b2,556 ± 3932,513 ± 4492,511 ± 4662,515 ± 4812,491 ± 4030.060.41
    Glucose and lipid metabolism
     Total glucose AUC (mg ⋅ min/mL)7.38 ± 0.647.32 ± 0.377.22 ± 0.517.25 ± 0.637.22 ± 0.737.32 ± 0.637.14 ± 0.517.11 ± 0.740.750.71
     Postprandial glucose AUC (mg ⋅ min/mL)2.73 ± 0.272.68 ± 0.342.59 ± 0.132.68 ± 0.292.64 ± 0.402.57 ± 0.292.64 ± 0.152.53 ± 0.270.790.63
     Total insulin AUC (IU ⋅ min/L)170 ± 102210 ± 83198 ± 97143 ± 49212 ± 118186 ± 123171 ± 87182 ± 1280.080.44
     Postprandial insulin AUC (IU ⋅ min/L)106 ± 64133 ± 57111 ± 5277 ± 22132 ± 85114 ± 80103 ± 55109 ± 790.190.31
     Total free fatty acid AUC (mEq ⋅ min/L)3.53 ± 0.703.76 ± 1.053.36 ± 0.313.37 ± 1.162.73 ± 0.863.20 ± 0.403.65 ± 1.093.76 ± 0.410.360.68
     Fasting total cholesterol (mg/dL)120 ± 24132 ± 24117 ± 16136 ± 110.13
     Fasting LDL (mg/dL)71 ± 2175 ± 2162 ± 1376 ± 100.20
     Fasting TG (mg/dL)57 ± 1668 ± 2768 ± 1565 ± 220.31
     Fasting HDL (mg/dL)38 ± 744 ± 741 ± 746 ± 4d0.03
    Adipokine
     Leptin AUC (ng ⋅ min/mL)16 ± 515 ± 614 ± 3b12 ± 2a,b29 ± 1526 ± 1125 ± 1225 ± 11c0.010.002
     Adiponectin AUC (pg ⋅ min/mL)99 ± 38103 ± 37117 ± 51b127 ± 49a,b78 ± 3177 ± 3274 ± 32c82 ± 38c0.00070.0003
     FGF21 AUC (pg ⋅ min/mL)333 ± 57411 ± 104343 ± 46460 ± 91a,b350 ± 25400 ± 80370 ± 37435 ± 750.280.10
    • Data are means ± SD. At the end of each testing month, subjects underwent acute thermometabolic evaluation at either 24°C or 19°C. ACTH, adrenocortotropic hormone.

    • aP < 0.05 compared with 24°C during acute thermometabolic evaluation each month;

    • bP < 0.05 (month 1 vs. 2),

    • cP < 0.05 (months 2 vs. 4), and

    • dP < 0.05 (months 1 vs. 4) compared with matching measurement at the same temperature performed at respective months as indicated.

PreviousNext
Back to top
Diabetes: 63 (11)

In this Issue

November 2014, 63(11)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Temperature-Acclimated Brown Adipose Tissue Modulates Insulin Sensitivity in Humans
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Temperature-Acclimated Brown Adipose Tissue Modulates Insulin Sensitivity in Humans
Paul Lee, Sheila Smith, Joyce Linderman, Amber B. Courville, Robert J. Brychta, William Dieckmann, Charlotte D. Werner, Kong Y. Chen, Francesco S. Celi
Diabetes Nov 2014, 63 (11) 3686-3698; DOI: 10.2337/db14-0513

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Temperature-Acclimated Brown Adipose Tissue Modulates Insulin Sensitivity in Humans
Paul Lee, Sheila Smith, Joyce Linderman, Amber B. Courville, Robert J. Brychta, William Dieckmann, Charlotte D. Werner, Kong Y. Chen, Francesco S. Celi
Diabetes Nov 2014, 63 (11) 3686-3698; DOI: 10.2337/db14-0513
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Discussion
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Ncor2/PPARα-Dependent Upregulation of MCUb in the Type 2 Diabetic Heart Impacts Cardiac Metabolic Flexibility and Function
  • Role of the Neutral Amino Acid Transporter SLC7A10 in Adipocyte Lipid Storage, Obesity, and Insulin Resistance
  • Heme Oxygenase-1 Regulates Ferrous Iron and Foxo1 in Control of Hepatic Gluconeogenesis
Show more Metabolism

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.